The Norwegian Research Council-financed project NCGC are joining forces with Norwegian Cancer Registry to establish a research platform for tumor-profiling in recruiting patients for clinical trials.
The objective is to make Norway an even more attractive location for the industry and to meet the industries specific needs. The first step in this work is to define a gene panel. In this connection the project team wants to get in contact with Oslo Cancer Cluster members who can give feedback on what targets should be included.
For more information, please contact:
More about NCGC here: cancergenomics.no